|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu M, Liu AM, Kampman E, Zhang ZF, Van't
Veer P, Wu DL, Wang PH, Yang J, Qin Y, Mu LN, et al: Green tea
drinking, high tea temperature and esophageal cancer in high- and
low-risk areas of Jiangsu Province, China: A population-based
case-control study. Int J Cancer. 124:1907–1913. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Paul S and Altorki N: Outcomes in the
management of esophageal cancer. J Surg Oncol. 110:599–610. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Alvarez E, Zhou W, Witta SE and Freed CR:
Characterization of the Bex gene family in humans, mice, and rats.
Gene. 357:18–28. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang L: Adaptive evolution and frequent
gene conversion in the brain expressed X-linked gene family in
mammals. Biochem Genet. 46:293–311. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Quentmeier H, Tonelli R, Geffers R,
Pession A, Uphoff CC and Drexler HG: Expression of BEX1 in
acute myeloid leukemia with MLL rearrangements. Leukemia.
19:1488–1489. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lindblad O, Li T, Su X, Sun J, Kabir NN,
Levander F, Zhao H, Lu G, Rönnstrand L and Kazi JU: BEX1 acts as a
tumor suppressor in acute myeloid leukemia. Oncotarget.
6:21395–21405. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ding K, Su Y, Pang L, Lu Q, Wang Z, Zhang
S, Zheng S, Mao J and Zhu Y: Inhibition of apoptosis by
downregulation of hBex1, a novel mechanism, contributes to the
chemoresistance of Bcr/Abl+ leukemic cells.
Carcinogenesis. 30:35–42. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Karakoula K, Jacques TS, Phipps KP,
Harkness W, Thompson D, Harding BN, Darling JL and Warr TJ:
Epigenetic genome-wide analysis identifies BEX1 as a
candidate tumour suppressor gene in paediatric intracranial
ependymoma. Cancer Lett. 346:34–44. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee CH, Wong TS, Chan JY, Lu SC, Lin P,
Cheng AJ, Chen YJ, Chang JS, Hsiao SH, Leu YW, et al: Epigenetic
regulation of the X-linked tumour suppressors BEX1 and
LDOC1 in oral squamous cell carcinoma. J Pathol.
230:298–309. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gao W, Li JZ, Chen SQ, Chu CY, Chan JY and
Wong TS: Decreased brain-expressed X-linked 4 (BEX4) expression
promotes growth of oral squamous cell carcinoma. J Exp Clin Cancer
Res. 35:922016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Naderi A, Liu J and Francis GD: A feedback
loop between BEX2 and ErbB2 mediated by c-Jun signaling in breast
cancer. Int J Cancer. 130:71–82. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Naderi A, Teschendorff AE, Beigel J,
Cariati M, Ellis IO, Brenton JD and Caldas C: BEX2 is overexpressed
in a subset of primary breast cancers and mediates nerve growth
factor/nuclear factor-kappaB inhibition of apoptosis in breast
cancer cell lines. Cancer Res. 67:6725–6736. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fischer C, Drexler HG, Reinhardt J,
Zaborski M and Quentmeier H: Epigenetic regulation of brain
expressed X-linked-2, a marker for acute myeloid leukemia with
mixed lineage leukemia rearrangements. Leukemia. 21:374–377. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou X, Xu X, Meng Q, Hu J, Zhi T, Shi Q
and Yu R: Bex2 is critical for migration and invasion in malignant
glioma cells. J Mol Neurosci. 50:78–87. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou X, Meng Q, Xu X, Zhi T, Shi Q, Wang Y
and Yu R: Bex2 regulates cell proliferation and apoptosis in
malignant glioma cells via the c-Jun NH2-terminal kinase pathway.
Biochem Biophys Res Commun. 427:574–580. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu Y, Xiao Q, Chen H, He J, Tan Y, Liu Y,
Wang Z, Yang Q, Shen X, Huang Y, et al: BEX2 promotes tumor
proliferation in colorectal cancer. Int J Biol Sci. 13:286–294.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Foltz G, Ryu GY, Yoon JG, Nelson T, Fahey
J, Frakes A, Lee H, Field L, Zander K, Sibenaller Z, et al:
Genome-wide analysis of epigenetic silencing identifies BEX1
and BEX2 as candidate tumor suppressor genes in malignant
glioma. Cancer Res. 66:6665–6674. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xiao Q, Hu Y, Liu Y, Wang Z, Geng H, Hu L,
Xu D, Wang K, Zheng L, Zheng S, et al: BEX1 promotes
imatinib-induced apoptosis by binding to and antagonizing BCL-2.
PLoS One. 9:e917822014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sethi G, Ahn KS, Sung B and Aggarwal BB:
Pinitol targets nuclear factor-kappaB activation pathway leading to
inhibition of gene products associated with proliferation,
apoptosis, invasion, and angiogenesis. Mol Cancer Ther.
7:1604–1614. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pikarsky E, Porat RM, Stein I, Abramovitch
R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and
Ben-Neriah Y: NF-kappaB functions as a tumour promoter in
inflammation-associated cancer. Nature. 431:461–466. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Karin M and Greten FR: NF-kappaB: Linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Karin M: Nuclear factor-kappaB in cancer
development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang F, He W, Fanghui P, Wang L and Fan Q:
NF-κBP65 promotes invasion and metastasis of oesophageal squamous
cell cancer by regulating matrix metalloproteinase-9 and
epithelial-to-mesenchymal transition. Cell Biol Int. 37:780–788.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kang MR, Kim MS, Kim SS, Ahn CH, Yoo NJ
and Lee SH: NF-κB signalling proteins p50/p105, p52/p100, RelA, and
IKKepsilon are over-expressed in oesophageal squamous cell
carcinomas. Pathology. 41:622–625. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Izzo JG, Malhotra U, Wu TT, Ensor J,
Luthra R, Lee JH, Swisher SG, Liao Z, Chao KS, Hittelman WN, et al:
Association of activated transcription factor nuclear factor kappab
with chemoradiation resistance and poor outcome in esophageal
carcinoma. J Clin Oncol. 24:748–754. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tian F, Zhang C, Tian W, Jiang Y and Zhang
X: Comparison of the effect of p65 siRNA and curcumin in promoting
apoptosis in esophageal squamous cell carcinoma cells and in nude
mice. Oncol Rep. 28:232–240. 2012.PubMed/NCBI
|
|
29
|
Tian F, Fan T, Jiang Y, Zhang X and Wang
X: A small interfering RNA targeting NF-κB p65 alone or combined
with 5-FU inhibits growth of esophageal squamous cell carcinoma in
nude mice. Pathol Res Pract. 208:32–38. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tian F, Zang WD, Hou WH, Liu HT and Xue
LX: Nuclear factor-κB signaling pathway constitutively activated in
esophageal squamous cell carcinoma cell lines and inhibition of
growth of cells by small interfering RNA. Acta Biochim Biophys Sin.
38:318–326. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Meng Q, Zhi T, Chao Y, Nie E, Xu X, Shi Q,
Hua L, Wang L, Zhan W, Wang Y, et al: Bex2 controls proliferation
of human glioblastoma cells through NF-κB signaling pathway. J Mol
Neurosci. 53:262–270. 2014. View Article : Google Scholar : PubMed/NCBI
|
